the association between transfusion independence and improved survival in myelofibrosis
Published 1 year ago • 151 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
3:12
transfusion independence and momelotinib in myelofibrosis
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
4:25
update on momelotinib for myelofibrosis
-
2:53
long-term safety of momelotinib in myelofibrosis: pooled data from three phase iii randomized trials
-
1:53
parsaclisib in myelofibrosis patients with suboptimal response to ruxolitinib
-
1:49
phase ii trial-in-progress of itacitinib in patients with myelofibrosis
-
3:56
the association between hemophilia and fracture risk: a systematic review and meta-analysis
-
58:27
laboratory nonconformance (event) management
-
14:40
primary myelofibrosis (pmf)
-
21:38
drawing the line: the rationale behind blood tube collection order
-
4:48
an insight into the management of cytopenias in mf
-
1:58
transfusion-independence associated with os in simplify-1 and simplfy-2
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:01
preconditioning prior to non-myeloablative matched sibling donor hsct in patients with scd
-
1:52
phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
-
2:13
collaboration and cooperation in hematology-oncology research
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
1:08
the 1st patient advocacy track at ebmt: making a difference for patients
-
2:31
achieving efficient collaboration between the registry and clinical partners